Annual ROE
-175.79%
-52.99%-43.15%
December 31, 2023
Summary
- As of February 8, 2025, ARQT annual return on equity is -175.79%, with the most recent change of -52.99% (-43.15%) on December 31, 2023.
- During the last 3 years, ARQT annual ROE has fallen by -125.65% (-250.60%).
- ARQT annual ROE is now -276.32% below its all-time high of 99.70%, reached on December 31, 2017.
Performance
ARQT ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-138.99%
+19.45%+12.28%
September 30, 2024
Summary
- As of February 8, 2025, ARQT quarterly return on equity is -138.99%, with the most recent change of +19.45% (+12.28%) on September 30, 2024.
- Over the past year, ARQT quarterly ROE has increased by +40.24% (+22.45%).
- ARQT quarterly ROE is now -252.64% below its all-time high of 91.06%, reached on September 30, 2019.
Performance
ARQT Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ARQT ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -43.1% | +22.4% |
| 3 y3 years | -250.6% | +22.4% |
| 5 y5 years | -319.0% | +22.4% |
ARQT ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -153.6% | at low | -157.0% | +40.1% |
| 5 y | 5-year | -372.2% | at low | -295.2% | +40.1% |
| alltime | all time | -276.3% | at low | -252.6% | +40.1% |
Arcutis Biotherapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -138.99%(-12.3%) |
| Jun 2024 | - | -158.44%(-15.4%) |
| Mar 2024 | - | -187.25%(-19.3%) |
| Dec 2023 | -175.79%(+43.2%) | -231.90%(+29.4%) |
| Sep 2023 | - | -179.23%(-2.9%) |
| Jun 2023 | - | -184.61%(+15.0%) |
| Mar 2023 | - | -160.51%(+19.8%) |
| Dec 2022 | -122.80%(+77.1%) | -134.03%(+9.7%) |
| Sep 2022 | - | -122.16%(+30.3%) |
| Jun 2022 | - | -93.72%(+32.7%) |
| Mar 2022 | - | -70.62%(+30.6%) |
| Dec 2021 | -69.32% | -54.09%(+19.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | -45.11%(-1.8%) |
| Jun 2021 | - | -45.92%(-11.8%) |
| Mar 2021 | - | -52.09%(-14.1%) |
| Dec 2020 | -50.14%(-177.6%) | -60.67%(-25.8%) |
| Sep 2020 | - | -81.74%(-24.8%) |
| Jun 2020 | - | -108.73%(-29.1%) |
| Mar 2020 | - | -153.39%(-315.5%) |
| Dec 2019 | 64.58%(-19.5%) | 71.19%(-21.8%) |
| Sep 2019 | - | 91.06%(+6.3%) |
| Jun 2019 | - | 85.67%(+67.6%) |
| Mar 2019 | - | 51.11%(+118.9%) |
| Dec 2018 | 80.27%(-19.5%) | 23.35% |
| Dec 2017 | 99.70% | - |
FAQ
- What is Arcutis Biotherapeutics annual return on equity?
- What is the all time high annual ROE for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual ROE year-on-year change?
- What is Arcutis Biotherapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly ROE year-on-year change?
What is Arcutis Biotherapeutics annual return on equity?
The current annual ROE of ARQT is -175.79%
What is the all time high annual ROE for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual return on equity is 99.70%
What is Arcutis Biotherapeutics annual ROE year-on-year change?
Over the past year, ARQT annual return on equity has changed by -52.99% (-43.15%)
What is Arcutis Biotherapeutics quarterly return on equity?
The current quarterly ROE of ARQT is -138.99%
What is the all time high quarterly ROE for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly return on equity is 91.06%
What is Arcutis Biotherapeutics quarterly ROE year-on-year change?
Over the past year, ARQT quarterly return on equity has changed by +40.24% (+22.45%)